These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33175535)

  • 1. Novel 2,7-Diazaspiro[4,4]nonane Derivatives to Inhibit Mouse and Human Osteoclast Activities and Prevent Bone Loss in Ovariectomized Mice without Affecting Bone Formation.
    Mounier L; Morel A; Ferrandez Y; Morko J; Vääräniemi J; Gilardone M; Roche D; Cherfils J; Blangy A
    J Med Chem; 2020 Nov; 63(22):13680-13694. PubMed ID: 33175535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.
    Idris AI; Greig IR; Bassonga-Landao E; Ralston SH; van 't Hof RJ
    Endocrinology; 2009 Jan; 150(1):5-13. PubMed ID: 18772231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alisol-B, a novel phyto-steroid, suppresses the RANKL-induced osteoclast formation and prevents bone loss in mice.
    Lee JW; Kobayashi Y; Nakamichi Y; Udagawa N; Takahashi N; Im NK; Seo HJ; Jeon WB; Yonezawa T; Cha BY; Woo JT
    Biochem Pharmacol; 2010 Aug; 80(3):352-61. PubMed ID: 20412788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitors.
    Van 't Hof RJ; Idris AI; Ridge SA; Dunford J; Greig IR; Ralston SH
    J Bone Miner Res; 2004 Oct; 19(10):1651-60. PubMed ID: 15355560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation.
    Vives V; Cres G; Richard C; Busson M; Ferrandez Y; Planson AG; Zeghouf M; Cherfils J; Malaval L; Blangy A
    Nat Commun; 2015 Feb; 6():6218. PubMed ID: 25645278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
    Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
    Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo.
    Idris AI; Landao-Bassonga E; Ralston SH
    Bone; 2010 Apr; 46(4):1089-99. PubMed ID: 20096813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss.
    Zhao Y; Huai Y; Jin J; Geng M; Li JX
    Menopause; 2011 Jun; 18(6):690-7. PubMed ID: 21228726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvia plebeia R.Br. inhibits signal transduction of IL-6 and prevents ovariectomy-induced bone loss by suppressing osteoclastogenesis.
    Kim MH; Jung K; Nam KH; Jang HJ; Lee SW; Kim Y; Park CS; Lee TH; Park JH; Choi JH; Rho MC; Oh HM
    Arch Pharm Res; 2016 Dec; 39(12):1671-1681. PubMed ID: 27539608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts.
    Vives V; Laurin M; Cres G; Larrousse P; Morichaud Z; Noel D; Côté JF; Blangy A
    J Bone Miner Res; 2011 May; 26(5):1099-110. PubMed ID: 21542010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arecoline suppresses RANKL-induced osteoclast differentiation in vitro and attenuates LPS-induced bone loss in vivo.
    Liu FL; Chen CL; Lai CC; Lee CC; Chang DM
    Phytomedicine; 2020 Apr; 69():153195. PubMed ID: 32200293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
    Van Beek ER; Löwik CW; Papapoulos SE
    Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
    Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
    Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tomatidine suppresses osteoclastogenesis and mitigates estrogen deficiency-induced bone mass loss by modulating TRAF6-mediated signaling.
    Hu B; Sun X; Yang Y; Ying Z; Meng J; Zhou C; Jiang G; Li S; Wu F; Zhao X; Zhu H; Wu H; Cai X; Shi Z; Yan S
    FASEB J; 2019 Feb; 33(2):2574-2586. PubMed ID: 30285579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption.
    Jun AY; Kim HJ; Park KK; Son KH; Lee DH; Woo MH; Kim YS; Lee SK; Chung WY
    Fitoterapia; 2012 Dec; 83(8):1523-31. PubMed ID: 22981503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts.
    Zhai Y; Li Y; Wang Y; Cui J; Feng K; Kong X; Chen L
    Eur J Pharmacol; 2017 Apr; 801():62-71. PubMed ID: 28283388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice.
    Alles N; Soysa NS; Hayashi J; Khan M; Shimoda A; Shimokawa H; Ritzeler O; Akiyoshi K; Aoki K; Ohya K
    Endocrinology; 2010 Oct; 151(10):4626-34. PubMed ID: 20810563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nacreous factors in preventing osteoporotic bone loss through both osteoblast activation and osteoclast inactivation.
    Kim H; Lee K; Ko CY; Kim HS; Shin HI; Kim T; Lee SH; Jeong D
    Biomaterials; 2012 Oct; 33(30):7489-96. PubMed ID: 22809648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumambrin A prevents OVX-induced osteoporosis
    Zhou L; Liu Q; Hong G; Song F; Zhao J; Yuan J; Xu J; Tan RX; Tickner J; Gu Q; Xu J
    FASEB J; 2019 Jun; 33(6):6726-6735. PubMed ID: 30807230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.